Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Management Board re-elects Vice-chair and starts budget discussions for 2010 10 Μάρτιος 2009Press releaseCorporate Orion Corporation withdraws its application for an extension of indication for Stalevo (levodopa/carbidopa/entacapone) 10 Μάρτιος 2009Press release Review of field safety data by the European Medicines Agency finds a goodsafety record for inactivated bluetongue emergency vaccines 20 Φεβρουάριος 2009Press releaseMedicines European Medicines Agency recommends continued vaccination with Gardasil 19 Φεβρουάριος 2009Press releaseMedicines European Medicines Agency recommends new contraindication and warning for Rasilez and other aliskiren medicines 19 Φεβρουάριος 2009Press releaseMedicines Meeting highlights from the Committee for Medicinal Products for Human Use,16-19 February 2009 19 Φεβρουάριος 2009Press releaseHuman European Medicines Agency recommends suspension of the marketing authorisation of Raptiva (efalizumab) 19 Φεβρουάριος 2009Press releaseHumanMedicines European Medicines Agency recommends authorisation of first bluetongue vaccine through centralised procedure 18 Φεβρουάριος 2009Press releaseMedicines Merck Sharp & Dohme Ltd withdraws its marketing authorisation application for Vorinostat MSD 17 Φεβρουάριος 2009Press release Committee for Advanced Therapies (CAT) elects chair and vice-chair 16 Φεβρουάριος 2009Press releaseAdvanced therapies 1 … 305 306 307 308 309 Page 309 of 384 310 311 312 313 … 384
Management Board re-elects Vice-chair and starts budget discussions for 2010 10 Μάρτιος 2009Press releaseCorporate
Orion Corporation withdraws its application for an extension of indication for Stalevo (levodopa/carbidopa/entacapone) 10 Μάρτιος 2009Press release
Review of field safety data by the European Medicines Agency finds a goodsafety record for inactivated bluetongue emergency vaccines 20 Φεβρουάριος 2009Press releaseMedicines
European Medicines Agency recommends continued vaccination with Gardasil 19 Φεβρουάριος 2009Press releaseMedicines
European Medicines Agency recommends new contraindication and warning for Rasilez and other aliskiren medicines 19 Φεβρουάριος 2009Press releaseMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use,16-19 February 2009 19 Φεβρουάριος 2009Press releaseHuman
European Medicines Agency recommends suspension of the marketing authorisation of Raptiva (efalizumab) 19 Φεβρουάριος 2009Press releaseHumanMedicines
European Medicines Agency recommends authorisation of first bluetongue vaccine through centralised procedure 18 Φεβρουάριος 2009Press releaseMedicines
Merck Sharp & Dohme Ltd withdraws its marketing authorisation application for Vorinostat MSD 17 Φεβρουάριος 2009Press release
Committee for Advanced Therapies (CAT) elects chair and vice-chair 16 Φεβρουάριος 2009Press releaseAdvanced therapies